{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:02:56Z","timestamp":1790740976923,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00125-011-2081-0","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T16:27:51Z","timestamp":1298996871000},"page":"1554-1566","source":"Crossref","is-referenced-by-count":112,"title":["Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal M\u00fcller cells"],"prefix":"10.1007","volume":"54","author":[{"given":"M.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. K.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.-Z.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-X.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"2081_CR1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932\u2013936","journal-title":"Nature"},{"key":"2081_CR2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/eye.2009.306","volume":"24","author":"A Scott","year":"2010","unstructured":"Scott A, Fruttiger M (2010) Oxygen-induced retinopathy: a model for vascular pathology in the retina. Eye (Lond) 24:416\u2013421","journal-title":"Eye (Lond)"},{"key":"2081_CR3","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469\u20131480","journal-title":"Mol Pharmacol"},{"key":"2081_CR4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/cvr\/cvq045","volume":"86","author":"S Rey","year":"2010","unstructured":"Rey S, Semenza GL (2010) Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res 86:236\u2013242","journal-title":"Cardiovasc Res"},{"key":"2081_CR5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10059-010-0067-2","volume":"29","author":"A Loboda","year":"2010","unstructured":"Loboda A, Jozkowicz A, Dulak J (2010) HIF-1 and HIF-2 transcription factors\u2014similar but not identical. Mol Cells 29:435\u2013442","journal-title":"Mol Cells"},{"key":"2081_CR6","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510\u20135514","journal-title":"Proc Natl Acad Sci USA"},{"key":"2081_CR7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271\u2013275","journal-title":"Nature"},{"key":"2081_CR8","doi-asserted-by":"crossref","first-page":"10430","DOI":"10.1073\/pnas.190332597","volume":"97","author":"T Kamura","year":"2000","unstructured":"Kamura T, Sato S, Iwai K, Czyzyk-Krzeska M, Conaway RC, Conaway JW (2000) Activation of HIF1alpha ubiquitination by a reconstituted von Hippel\u2013Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA 97:10430\u201310435","journal-title":"Proc Natl Acad Sci USA"},{"key":"2081_CR9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan M, Kondo K, Yang H et al (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292:464\u2013468","journal-title":"Science"},{"key":"2081_CR10","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","volume":"292","author":"P Jaakkola","year":"2001","unstructured":"Jaakkola P, Mole DR, Tian YM et al (2001) Targeting of HIF-alpha to the von Hippel\u2013Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468\u2013472","journal-title":"Science"},{"key":"2081_CR11","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","volume":"98","author":"F Yu","year":"2001","unstructured":"Yu F, White SB, Zhao Q, Lee FS (2001) HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 98:9630\u20139635","journal-title":"Proc Natl Acad Sci USA"},{"key":"2081_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","volume":"107","author":"AC Epstein","year":"2001","unstructured":"Epstein AC, Gleadle JM, McNeill LA et al (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43\u201354","journal-title":"Cell"},{"key":"2081_CR13","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","volume":"294","author":"RK Bruick","year":"2001","unstructured":"Bruick RK, McKnight SL (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294:1337\u20131340","journal-title":"Science"},{"key":"2081_CR14","doi-asserted-by":"crossref","unstructured":"Semenza GL (2007) Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007: cm8","DOI":"10.1126\/stke.4072007cm8"},{"key":"2081_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/path.2611","volume":"219","author":"Y Bai","year":"2009","unstructured":"Bai Y, Ma JX, Guo J et al (2009) Muller cell-derived VEGF is a significant contributor to retinal neovascularization. J Pathol 219:446\u2013454","journal-title":"J Pathol"},{"key":"2081_CR16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.visres.2009.01.012","volume":"49","author":"Y Ueki","year":"2009","unstructured":"Ueki Y, Ash JD, Zhu M, Zheng L, Le YZ (2009) Expression of Cre recombinase in retinal Muller cells. Vis Res 49:615\u2013621","journal-title":"Vis Res"},{"key":"2081_CR17","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/j.1460-9568.2009.06781.x","volume":"29","author":"M Thiersch","year":"2009","unstructured":"Thiersch M, Lange C, Joly S et al (2009) Retinal neuroprotection by hypoxic preconditioning is independent of hypoxia-inducible factor-1 alpha expression in photoreceptors. Eur J Neurosci 29:2291\u20132302","journal-title":"Eur J Neurosci"},{"key":"2081_CR18","first-page":"182","volume":"40","author":"H Ozaki","year":"1999","unstructured":"Ozaki H, Yu AY, Della N et al (1999) Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40:182\u2013189","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2081_CR19","first-page":"4010","volume":"60","author":"HE Ryan","year":"2000","unstructured":"Ryan HE, Poloni M, McNulty W et al (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60:4010\u20134015","journal-title":"Cancer Res"},{"key":"2081_CR20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ydbio.2006.07.029","volume":"299","author":"AV Das","year":"2006","unstructured":"Das AV, Mallya KB, Zhao X et al (2006) Neural stem cell properties of Muller glia in the mammalian retina: regulation by Notch and Wnt signaling. Dev Biol 299:283\u2013302","journal-title":"Dev Biol"},{"key":"2081_CR21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mvr.2009.02.005","volume":"78","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Moiseyev G, Zhou KK, Chen D, Ma JX (2009) Photoreceptor degeneration and retinal inflammation induced by very low-density lipoprotein receptor deficiency. Microvasc Res 78:119\u2013127","journal-title":"Microvasc Res"},{"key":"2081_CR22","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1167\/iovs.04-0247","volume":"45","author":"PM Martin","year":"2004","unstructured":"Martin PM, Roon P, van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330\u20133336","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2081_CR23","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/db08-1327","volume":"58","author":"K Park","year":"2009","unstructured":"Park K, Chen Y, Hu Y et al (2009) Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage. Diabetes 58:1902\u20131913","journal-title":"Diabetes"},{"key":"2081_CR24","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1167\/iovs.05-0965","volume":"47","author":"Y Chen","year":"2006","unstructured":"Chen Y, Moiseyev G, Takahashi Y, Ma JX (2006) RPE65 gene delivery restores isomerohydrolase activity and prevents early cone loss in Rpe65 \u2013\/\u2013 mice. Invest Ophthalmol Vis Sci 47:1177\u20131184","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2081_CR25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s001250051685","volume":"44","author":"D Zhang","year":"2001","unstructured":"Zhang D, Kaufman PL, Gao G, Saunders RA, Ma JX (2001) Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats. Diabetologia 44:757\u2013765","journal-title":"Diabetologia"},{"key":"2081_CR26","first-page":"1168","volume":"38","author":"J Browning","year":"1997","unstructured":"Browning J, Wylie CK, Gole G (1997) Quantification of oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 38:1168\u20131174","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2081_CR27","first-page":"101","volume":"35","author":"LE Smith","year":"1994","unstructured":"Smith LE, Wesolowski E, McLellan A et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2081_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.preteyeres.2007.12.001","volume":"27","author":"N Cheung","year":"2008","unstructured":"Cheung N, Wong TY (2008) Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 27:161\u2013176","journal-title":"Prog Retin Eye Res"},{"key":"2081_CR29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung N, Mitchell P, Wong TY (2010) Diabetic retinopathy. Lancet 376:124\u2013136","journal-title":"Lancet"},{"key":"2081_CR30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1124\/mol.109.061366","volume":"77","author":"M DeNiro","year":"2010","unstructured":"DeNiro M, Al-Halafi A, Al-Mohanna FH, Alsmadi O, Al-Mohanna FA (2010) Pleiotropic effects of YC-1 selectively inhibit pathological retinal neovascularization and promote physiological revascularization in a mouse model of oxygen-induced retinopathy. Mol Pharmacol 77:348\u2013367","journal-title":"Mol Pharmacol"},{"key":"2081_CR31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1556\/APhysiol.96.2009.1.2","volume":"96","author":"JM Adams","year":"2009","unstructured":"Adams JM, Difazio LT, Rolandelli RH et al (2009) HIF-1: a key mediator in hypoxia. Acta Physiol Hung 96:19\u201328","journal-title":"Acta Physiol Hung"},{"key":"2081_CR32","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","volume":"92","author":"LP Aiello","year":"1995","unstructured":"Aiello LP, Pierce EA, Foley ED et al (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457\u201310461","journal-title":"Proc Natl Acad Sci USA"},{"key":"2081_CR33","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M et al (2006) Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 355:1432\u20131444","journal-title":"N Engl J Med"},{"key":"2081_CR34","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","volume":"93","author":"BD Kelly","year":"2003","unstructured":"Kelly BD, Hackett SF, Hirota K et al (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074\u20131081","journal-title":"Circ Res"},{"key":"2081_CR35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"EA Pierce","year":"1995","unstructured":"Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905\u2013909","journal-title":"Proc Natl Acad Sci USA"},{"key":"2081_CR36","first-page":"36","volume":"38","author":"RH Amin","year":"1997","unstructured":"Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW (1997) Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36\u201347","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2081_CR37","doi-asserted-by":"crossref","first-page":"10836","DOI":"10.1073\/pnas.96.19.10836","volume":"96","author":"K Miyamoto","year":"1999","unstructured":"Miyamoto K, Khosrof S, Bursell SE et al (1999) Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA 96:10836\u201310841","journal-title":"Proc Natl Acad Sci USA"},{"key":"2081_CR38","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","volume":"4","author":"KM Connor","year":"2009","unstructured":"Connor KM, Krah NM, Dennison RJ et al (2009) Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis. Nat Protoc 4:1565\u20131573","journal-title":"Nat Protoc"},{"key":"2081_CR39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neulet.2004.10.050","volume":"374","author":"JC Chavez","year":"2005","unstructured":"Chavez JC, Almhanna K, Berti-Mattera LN (2005) Transient expression of hypoxia-inducible factor-1 alpha and target genes in peripheral nerves from diabetic rats. Neurosci Lett 374:179\u2013182","journal-title":"Neurosci Lett"},{"key":"2081_CR40","doi-asserted-by":"crossref","first-page":"37997","DOI":"10.1074\/jbc.M401339200","volume":"279","author":"T Kondo","year":"2004","unstructured":"Kondo T, Kahn CR (2004) Altered insulin signaling in retinal tissue in diabetic states. J Biol Chem 279:37997\u201338006","journal-title":"J Biol Chem"},{"key":"2081_CR41","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.2337\/db09-1420","volume":"59","author":"J Wang","year":"2010","unstructured":"Wang J, Xu X, Elliott MH, Zhu M, Le YZ (2010) Muller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage. Diabetes 59:2297\u20132305","journal-title":"Diabetes"},{"key":"2081_CR42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.exer.2009.12.002","volume":"90","author":"WS Wright","year":"2010","unstructured":"Wright WS, McElhatten RM, Messina JE, Harris NR (2010) Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats. Exp Eye Res 90:405\u2013412","journal-title":"Exp Eye Res"},{"key":"2081_CR43","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)62255-9","volume":"166","author":"SX Zhang","year":"2005","unstructured":"Zhang SX, Ma JX, Sima J et al (2005) Genetic difference in susceptibility to the blood\u2013retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am J Pathol 166:313\u2013321","journal-title":"Am J Pathol"},{"key":"2081_CR44","first-page":"806783","volume":"2011","author":"Y-Z Le","year":"2011","unstructured":"Le Y-Z (2011) Conditional gene targeting: dissecting the cellular mechanisms of retinal degenerations. J Ophthalmol 2011:806783","journal-title":"J Ophthalmol"},{"key":"2081_CR45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","volume":"171","author":"K Nishijima","year":"2007","unstructured":"Nishijima K, Ng YS, Zhong L et al (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171:53\u201367","journal-title":"Am J Pathol"},{"key":"2081_CR46","first-page":"RA89","volume":"10","author":"J Josko","year":"2004","unstructured":"Josko J, Mazurek M (2004) Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 10:RA89\u2013RA98","journal-title":"Med Sci Monit"},{"key":"2081_CR47","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40:294\u2013309","journal-title":"Mol Cell"},{"key":"2081_CR48","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.2337\/diabetes.53.12.3226","volume":"53","author":"SB Catrina","year":"2004","unstructured":"Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L (2004) Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function. Diabetes 53:3226\u20133232","journal-title":"Diabetes"},{"key":"2081_CR49","doi-asserted-by":"crossref","first-page":"e11103","DOI":"10.1371\/journal.pone.0011103","volume":"5","author":"FM Mowat","year":"2010","unstructured":"Mowat FM, Luhmann UF, Smith AJ et al (2010) HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS ONE 5:e11103","journal-title":"PLoS ONE"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2081-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-011-2081-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-011-2081-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T18:40:04Z","timestamp":1560019204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-011-2081-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["2081"],"URL":"https:\/\/doi.org\/10.1007\/s00125-011-2081-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,1]]}}}